Linked Life Data

10573057

Source:http://linkedlifedata.com/resource/pubmed/id/10573057

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-12-2
pubmed:abstractText
We hypothesized that endothelin-A (ET-A) receptor activation plays a central role in intestinal ischemia-reperfusion-induced hemodynamic changes and may trigger the process of mucosal barrier destruction. Our aims were to investigate and compare the effects of systemic and intragraft ET-A receptor antagonist therapy during the early revascularization phase of small bowel transplants.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1231-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion.
pubmed:affiliation
Institute of Experimental Surgery and Department of Surgery, Szent-Györgyi Albert Medical University, Pécsi u, Hungary.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't